Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page
- Check3 days agoChange DetectedThe Study Results section has been populated with phase 3 trial results for setmelanotide in Bardet-Biedl and Alström syndromes, including primary and secondary outcomes and hunger data. The page now reflects the completion status and availability of published results, providing context on efficacy and appetite effects over the treatment period.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small technical update to the page version. No substantive content changes are indicated by this revision.SummaryDifference0.3%

- Check18 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor administrative update to the page. It does not reflect changes to study details or participant-related information.SummaryDifference0.3%

- Check25 days agoChange DetectedNo text additions or deletions were provided; the page content appears unchanged based on the supplied change data.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now indicates that recruitment is closed and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision notice (Revision: v3.6.0).SummaryDifference0.5%

- Check39 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a version refresh of the study record. This appears to be a minor update or correction rather than a change to study design or results.SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.